TUB and myeloid sarcoma: Another study compared serum and CSF levels and intrathecal synthesis of anti-NfL IgG, anti-NfM IgG, and anti-TUB (tubulin) IgG, between MS patients and those with other neurological diseases (Fialová et al., 2009).